Background illustration for clinical trials search

Paid Clinical Trials Ontario

Discover 2,726 paid clinical trials in Ontario. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.

Filter
1

Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)

for
Ganglioneuroblastoma, Ganglioneuroblastoma, Nodular,
Location: St. John's, Halifax, Bangor ME, Scarborough ME,
Sponsor: Children's Oncology Group

Sex: All

Age: 1 - 30

Code: NCT03126916

Phase 3, Recruiting

Safety and Efficacy of APC-0101 in Preterm Infants With Respiratory Distress Syndrome

for
Respiratory Distress Syndrome, Pre-term Infants
Location: Halifax, Boston MA, Quebec, Valhalla NY, The Bronx NY,
Sponsor: Aerogen Pharma Limited

Sex: All

Age: 0

Code: NCT06776783

Phase 3, Recruiting

A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors

for
Advanced/Metastatic Solid Tumors, Bladder Cancer,
Location: Boston MA, Newton MA, New Haven CT, Trumbull CT,
Sponsor: Pfizer

Sex: All

Age: 18+

Code: NCT07090499

Phase 1, Recruiting

A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis

for
Ulcerative Colitis
Location: Providence RI, Worcester MA, Maspeth NY, New York NY,
Sponsor: Sanofi

Sex: All

Age: 16 - 70+

Code: NCT07185009

Phase 3, Recruiting

Intra-articular Corticosteroid With Hyaluronic Acid Plus Physiotherapy for Hip Pathologies (NON-OP HIP)

for
Osteoarthritis, Femoroacetabular Impingement Syndrome,
Location: Hamilton
Sponsor: ArthroBiologix Inc.

Sex: All

Age: 40 - 60

Code: NCT06653985

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease

for
Crohn's Disease
Location: Boston MA, Providence RI, Worcester MA, New Haven CT,
Sponsor: Sanofi

Sex: All

Age: 16 - 70+

Code: NCT07184931

Phase 3, Recruiting

TLN-372 in Advanced KRAS Mutant Solid Tumors

for
KRAS Mutant Solid Tumors
Location: Boston MA, New York NY, Toronto, Grand Rapids MI,
Sponsor: Treeline Biosciences, Inc.

Sex: All

Age: 18+

Code: NCT07204340

Phase 1, Recruiting

A Study of Surovatamig (AZD0486) Plus Rituximab in Previously Untreated Follicular Lymphoma Patients

for
Untreated Follicular Lymphoma
Location: Halifax, New Haven CT, Quebec, Chicoutimi, New York NY,
Sponsor: AstraZeneca

Sex: All

Age: 18 - 70+

Code: NCT06549595

Phase 3, Recruiting

A Study to Determine the Recommended Dose and Schedule, and Evaluate the Safety and Preliminary Efficacy of Mezigdomide in Combination With Elranatamab in Participants With Relapsed and/or Refractory Multiple Myeloma

for
Multiple Myeloma
Location: Halifax, New Haven CT, Hackensack NJ, Toronto,
Sponsor: Celgene

Sex: All

Age: 18+

Code: NCT06988488

Phase 1, Phase 2, Recruiting

Study of ASP2957 in Male Participants With X-linked Myotubular Myopathy Who Need Ventilators

for
X-Linked Myotubular Myopathy
Location: Boston MA, Toronto, Chicago IL, Dallas TX, Portland OR
Sponsor: Astellas Gene Therapies

Sex: Male

Age: 0 - 3

Code: NCT07052929

Phase 1, Phase 2, Recruiting

Analysis of Clinical Outcomes in Patients Undergoing Magnetic Resonance-Guided Focused Ultrasound for Medication-Refractory Tremor

for
Essential Tremor, Essential Tremor, Movement Disorders
Location: Toronto
Sponsor: Sunnybrook Health Sciences Centre

Sex: All

Age: 22+

Code: NCT07212244

Recruiting

Open-label Extension Study in Participants With Early Alzheimer's Disease

for
Alzheimer's Disease
Location: Sherbrooke, Toms River NJ, Staten Island NY,
Sponsor: GlaxoSmithKline

Sex: All

Age: 50 - 70+

Code: NCT07105709

Phase 2, Recruiting

A First in Human Study to Assess the Safety, Tolerability, and Pharmacokinetics of EDK060 in Adults With CMT1A.

for
Charcot-Marie-Tooth Disease, Type 1A
Location: Sherbrooke, Montreal, Ottawa
Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 18 - 60

Code: NCT07140614

Phase 1, Recruiting

Pivotal Study of the Silk Vista Baby Flow Diverters in the Treatment of Unruptured Intracranial Aneurysms (PIONEER)

for
Intracranial Aneurysm
Location: Springfield MA, Buffalo NY, Toronto, Jacksonville FL,
Sponsor: Balt USA

Sex: All

Age: 22 - 70+

Code: NCT07225075

Recruiting

A Study of 177Lu-FAP-2286 in Advanced Solid Tumors

for
Solid Tumor
Location: New York NY, Montreal, Chapel Hill NC, Miami FL,
Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 18+

Code: NCT04939610

Phase 1, Phase 2, Recruiting

A Study to Evaluate the Maintenance Effect of Osavampator as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)

for
Major Depressive Disorder
Location: Glen Oaks NY, Kingston, Miami Gardens FL, Roanoke VA,
Sponsor: Neurocrine Biosciences

Sex: All

Age: 18+

Code: NCT07196501

Phase 3, Recruiting

Sputum Cytometry Guided Management for the Elimination of Chronic Cough in Patients With ILD

for
ILD
Location: Hamilton
Sponsor: McMaster University

Sex: All

Age: 18+

Code: NCT05086432

Recruiting

A Long-term Treatment Extension Study of Niraparib in Participants Who Completed a Prior GlaxoSmithKline/TESARO-sponsored Niraparib Study

for
Ovarian Neoplasms, Breast Neoplasms
Location: Boston MA, Lake Success NY, Morristown NJ, Toronto,
Sponsor: GlaxoSmithKline

Sex: All

Age: 18+

Code: NCT04641247

Phase 2, Recruiting

Safety and Feasibility of FUS Next Generation Dome Helmet (NGDH) to Perform Neuromodulation in Patients With Treatment Refractory Obsessive Compulsive Disorder (OCD)

for
OCD, Obsessive-Compulsive Disorder (OCD),
Location: Toronto
Sponsor: Sunnybrook Health Sciences Centre

Sex: All

Age: 18 - 70+

Code: NCT07704632

Recruiting

A Study Evaluating the Efficacy and Safety of Risvutatug Rezetecan in Participants With Advanced Sarcomas (EMBOLD Sarcoma-202)

for
Sarcoma
Location: Toronto, Montreal, West Valley City UT
Sponsor: GlaxoSmithKline

Sex: All

Age: 0+

Code: NCT07602777

Phase 1, Phase 2, Recruiting

Popular cities in Ontario

Toronto